EUVIMEDEUVIMED entdecken
Crossref

Comparison of Clinicopathologic Characteristics and Survival Outcome Between Invasive Papillary Carcinoma and Invasive Ductal Carcinoma

Vahid Zangouri, Negin Nourinejad, Souzan Soufizadeh Balaneji, Payam Nozad, Ali Ghaeini Hesarooeih, Seyed Amin Mousavi, Aliey Ranjbar, Morteza Amestejani, Masoumeh Ghoddusi Johari, Mehdi Shariat, Maral Mokhtari

Surgical Practice · 16.11.2026

DOI: 10.1111/1744-1633.70114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Practice, online erschienen am 16.11.2026. Verfasst von Vahid Zangouri und 10 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Invasive papillary carcinoma (IPC) of the breast is an exceptionally rare histological subtype. This study compared the clinicopathological characteristics, biomarker expression profiles and survival outcomes of IPC with those of invasive ductal carcinoma of no special type (IDC‐NST). Materials and Methods The medical records of 6599 patients treated at the Breast Disease Research Center between December 1993 and December 2021 were retrospectively reviewed. Patients were categorized into IPC ( n = 27) and IDC ( n = 6572) groups. Tumour size, axillary lymph node status, pathologic stage, histologic grade, hormone receptor status (ER, PR), HER2 status, surgical management, adjuvant therapies and survival outcomes were analysed and compared. Survival distributions were evaluated using Kaplan–Meier curves and compared using the log‐rank test.

Results

Patients with IPC were significantly older at presentation than those with IDC (mean age: 58.5 ± 14.0 vs. 49.0 ± 12.4 years, p = 0.02). Compared with IDC, IPC tumours demonstrated significantly less aggressive features, including a lower rate of axillary lymph node involvement (14.8% vs. 39.2%, p < 0.001) and a lower incidence of lymphovascular invasion (14.9% vs. 53.3%, p < 0.001). IPC tumours were predominantly low‐grade (Grade I: 70.3% vs. 20.5%, p < 0.001) and presented more frequently at Stage I (85.1% vs. 39.8%, p < 0.001). Adjuvant chemotherapy was administered significantly less often in the IPC group than in the IDC group (62.9% vs. 94.9%, p < 0.001). In stage‐specific analyses of Stage I disease, IPC exhibited favourable 5‐year disease‐free survival (81% vs. 69%, p = 0.008) and 5‐year overall survival (85% vs. 75%, p = 0.001) compared with Stage I IDC.

Conclusion

IPC is a rare tumour type that presents unique clinicopathological characteristics and is associated with a higher rate of breast‐conserving surgery and a favourable prognosis than IDC.

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Zangouri, V., Nourinejad, N., Balaneji, S. S., Nozad, P., Hesarooeih, A. G., Mousavi, S. A., Ranjbar, A., Amestejani, M., Johari, M. G., Shariat, M., & Mokhtari, M. (2026). Comparison of Clinicopathologic Characteristics and Survival Outcome Between Invasive Papillary Carcinoma and Invasive Ductal Carcinoma. Surgical Practice. https://doi.org/10.1111/1744-1633.70114

Vancouver

Zangouri V, Nourinejad N, Balaneji SS, Nozad P, Hesarooeih AG, Mousavi SA, et al. Comparison of Clinicopathologic Characteristics and Survival Outcome Between Invasive Papillary Carcinoma and Invasive Ductal Carcinoma. Surgical Practice. 2026. doi:10.1111/1744-1633.70114

BibTeX
@article{Zangouri2026,
  author = {Zangouri, Vahid and Nourinejad, Negin and Balaneji, Souzan Soufizadeh and Nozad, Payam and Hesarooeih, Ali Ghaeini and Mousavi, Seyed Amin and Ranjbar, Aliey and Amestejani, Morteza and Johari, Masoumeh Ghoddusi and Shariat, Mehdi and Mokhtari, Maral},
  title = {Comparison of Clinicopathologic Characteristics and Survival Outcome Between Invasive Papillary Carcinoma and Invasive Ductal Carcinoma},
  journal = {Surgical Practice},
  year = {2026},
  doi = {10.1111/1744-1633.70114}
}
Kostenlos starten →